PDGFRB and neoplasm: Zhang et al. [28] revealed that CD44s was preferentially and predominantly expressed in breast CSCs and promotes CSCs activities and tumour initiation through signal transducer and activator of transcription 3 (STAT3) via PDGFRβ/STAT3 signalling pathways.